The role of elastography in non-alcoholic fatty liver disease
Antonio Liguori, Maria Elena Ainora, Laura Riccardi, Nicoletta De Matthaeis, Fabrizio Pizzolante, Antonio Gasbarrini, Maria Assunta Zocco, Antonio Grieco, Gianludovico Rapaccini, Luca Miele
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its prevalence is even higher in patients with risk factors such as type 2 diabetes and obesity. Liver biopsy is the gold standard for diagnosis of non-alcoholic steatohepatitis (NASH), particularly for the assessment of fibrosis stage that is a key prognostic factor. Noninvasive methods for assessment of liver fibrosis are a huge need in contemporary hepatology in order to stratify patient's risk of advanced and progressive liver disease. In this perspective different imaging techniques have been developed in last decades and showed high performance in liver fibrosis evaluation. Strengths and weaknesses of all imaging methods are summarized in this review.